VRT.CN - Veritas Pharma Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue2018-04-302017-04-302016-04-302015-04-30
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development96.36144.99444.99444.994
Selling General and Administrative7,195.6851,097.962457.38774.483
Non Recurring----
Others----
Total Operating Expenses10,508.0972,342.269820.482213.611
Operating Income or Loss-10,508.097-2,342.269-820.482-213.611
Income from Continuing Operations
Total Other Income/Expenses Net-3,493.764-606.375-93.228-42.594
Earnings Before Interest and Taxes-10,508.097-2,342.269-820.482-213.611
Interest Expense--33.546-49.596-49.596
Income Before Tax-14,001.861-2,948.644-913.71-256.205
Income Tax Expense----
Minority Interest-472.389472.389472.389
Net Income From Continuing Ops-14,001.861-2,948.644-913.71-256.205
Non-recurring Events
Discontinued Operations---247.716-472.58
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-13,863.241-2,930.635-1,161.426-728.785
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-13,863.241-2,930.635-1,161.426-728.785